1 Min Read
Feb 14 (Reuters) - Sanofi SA :
* Sanofi initiates phase 2 clinical trial to evaluate therapy for genetic form of parkinson’s disease Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.